185 related articles for article (PubMed ID: 35245734)
1. Exploring the potential role of rab5 protein in endo-lysosomal impairment in Alzheimer's disease.
Behl T; Kaur D; Sehgal A; Singh S; Makeen HA; Albratty M; Abdellatif AAH; Dachani SR; Bungau S
Biomed Pharmacother; 2022 Apr; 148():112773. PubMed ID: 35245734
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of Rab5-mediated endocytic pathways in Alzheimer's disease.
Xu W; Fang F; Ding J; Wu C
Traffic; 2018 Apr; 19(4):253-262. PubMed ID: 29314494
[TBL] [Abstract][Full Text] [Related]
3. Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease.
Sjödin S; Brinkmalm G; Öhrfelt A; Parnetti L; Paciotti S; Hansson O; Hardy J; Blennow K; Zetterberg H; Brinkmalm A
Alzheimers Res Ther; 2019 Sep; 11(1):82. PubMed ID: 31521194
[TBL] [Abstract][Full Text] [Related]
4. Endo-lysosomal dysregulations and late-onset Alzheimer's disease: impact of genetic risk factors.
Van Acker ZP; Bretou M; Annaert W
Mol Neurodegener; 2019 Jun; 14(1):20. PubMed ID: 31159836
[TBL] [Abstract][Full Text] [Related]
5. Genetic variation within endolysosomal system is associated with late-onset Alzheimer's disease.
Gao S; Casey AE; Sargeant TJ; Mäkinen VP
Brain; 2018 Sep; 141(9):2711-2720. PubMed ID: 30124770
[TBL] [Abstract][Full Text] [Related]
6. Endo-lysosomal and autophagic dysfunction: a driving factor in Alzheimer's disease?
Whyte LS; Lau AA; Hemsley KM; Hopwood JJ; Sargeant TJ
J Neurochem; 2017 Mar; 140(5):703-717. PubMed ID: 28027395
[TBL] [Abstract][Full Text] [Related]
7. Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis.
Cao J; Zhong MB; Toro CA; Zhang L; Cai D
Neurosci Lett; 2019 Jun; 703():68-78. PubMed ID: 30890471
[TBL] [Abstract][Full Text] [Related]
8. Endosomal Dysfunction Induced by Directly Overactivating Rab5 Recapitulates Prodromal and Neurodegenerative Features of Alzheimer's Disease.
Pensalfini A; Kim S; Subbanna S; Bleiwas C; Goulbourne CN; Stavrides PH; Jiang Y; Lee JH; Darji S; Pawlik M; Huo C; Peddy J; Berg MJ; Smiley JF; Basavarajappa BS; Nixon RA
Cell Rep; 2020 Nov; 33(8):108420. PubMed ID: 33238112
[TBL] [Abstract][Full Text] [Related]
9. Focusing on cellular biomarkers: The endo-lysosomal pathway in Down syndrome.
Botté A; Potier MC
Prog Brain Res; 2020; 251():209-243. PubMed ID: 32057308
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of amyloid-β endocytic trafficking and lysosomal degradation by apolipoprotein E isoforms.
Li J; Kanekiyo T; Shinohara M; Zhang Y; LaDu MJ; Xu H; Bu G
J Biol Chem; 2012 Dec; 287(53):44593-601. PubMed ID: 23132858
[TBL] [Abstract][Full Text] [Related]
11. The Interplay Between Apolipoprotein E4 and the Autophagic-Endocytic-Lysosomal Axis.
Schmukler E; Michaelson DM; Pinkas-Kramarski R
Mol Neurobiol; 2018 Aug; 55(8):6863-6880. PubMed ID: 29353455
[TBL] [Abstract][Full Text] [Related]
12. GSK-3-TSC axis governs lysosomal acidification through autophagy and endocytic pathways.
Avrahami L; Paz R; Dominko K; Hecimovic S; Bucci C; Eldar-Finkelman H
Cell Signal; 2020 Jul; 71():109597. PubMed ID: 32173369
[TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease and the autophagic-lysosomal system.
Chung KM; Hernández N; Sproul AA; Yu WH
Neurosci Lett; 2019 Apr; 697():49-58. PubMed ID: 29758300
[TBL] [Abstract][Full Text] [Related]
14. Reversal of autophagy dysfunction in the TgCRND8 mouse model of Alzheimer's disease ameliorates amyloid pathologies and memory deficits.
Yang DS; Stavrides P; Mohan PS; Kaushik S; Kumar A; Ohno M; Schmidt SD; Wesson D; Bandyopadhyay U; Jiang Y; Pawlik M; Peterhoff CM; Yang AJ; Wilson DA; St George-Hyslop P; Westaway D; Mathews PM; Levy E; Cuervo AM; Nixon RA
Brain; 2011 Jan; 134(Pt 1):258-77. PubMed ID: 21186265
[TBL] [Abstract][Full Text] [Related]
15. Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease.
Colacurcio DJ; Pensalfini A; Jiang Y; Nixon RA
Free Radic Biol Med; 2018 Jan; 114():40-51. PubMed ID: 28988799
[TBL] [Abstract][Full Text] [Related]
16. Endo-lysosomal Aβ concentration and pH trigger formation of Aβ oligomers that potently induce Tau missorting.
Schützmann MP; Hasecke F; Bachmann S; Zielinski M; Hänsch S; Schröder GF; Zempel H; Hoyer W
Nat Commun; 2021 Jul; 12(1):4634. PubMed ID: 34330900
[TBL] [Abstract][Full Text] [Related]
17. Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease.
Nixon RA
FASEB J; 2017 Jul; 31(7):2729-2743. PubMed ID: 28663518
[TBL] [Abstract][Full Text] [Related]
18. Down syndrome fibroblast model of Alzheimer-related endosome pathology: accelerated endocytosis promotes late endocytic defects.
Cataldo AM; Mathews PM; Boiteau AB; Hassinger LC; Peterhoff CM; Jiang Y; Mullaney K; Neve RL; Gruenberg J; Nixon RA
Am J Pathol; 2008 Aug; 173(2):370-84. PubMed ID: 18535180
[TBL] [Abstract][Full Text] [Related]
19. Neuronal autophagy: self-eating or self-cannibalism in Alzheimer's disease.
Ułamek-Kozioł M; Furmaga-Jabłońska W; Januszewski S; Brzozowska J; Sciślewska M; Jabłoński M; Pluta R
Neurochem Res; 2013 Sep; 38(9):1769-73. PubMed ID: 23737325
[TBL] [Abstract][Full Text] [Related]
20. Assessing Rab5 Activation in Health and Disease.
Pensalfini A; Jiang Y; Kim S; Nixon RA
Methods Mol Biol; 2021; 2293():273-294. PubMed ID: 34453725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
